Sunday, July 3, 2022
  • Janam TV Malayalam
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Services
Janam TV English
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto
No Result
View All Result
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto
No Result
View All Result
Janam TV English
No Result
View All Result
  • News
  • Business
  • Defence
  • Health
Home News India

DCGI approves DRDO’s anti-COVID oral drug ‘2-DG’ for emergency use

by Janam Web Desk
May 8, 2021, 04:43 pm IST
in India, Health

The Drug Controller General of India (DCGI) has approved the emergency use of DRDO’s anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as adjunct therapy in moderate to severe COVID-19 patients.

On May 1, the DCGI granted permission for ‘Emergency Use’ of this drug.

Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty in the country.

After taking this drug, it was found that the patients have less dependence on oxygen while recovering from Coronavirus infection.

The drug comes in powder form in sachet, which is taken orally by dissolving it in water. It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique, the DRDO said in a statement today.

In the ongoing second COVID-19 wave, a large number of patients are facing severe oxygen dependency and need hospitalisation. The drug is expected to save precious lives due to the mechanism of operation of the drug in infected cells. This also reduces the hospital stay of COVID-19 patients.

This drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad.

Tags: DCGIDRDOCOVID oral drugCOVID 19 Drug2-DGMAINFEATURED
Share12TweetSendShare

Related News

Udaipur beheading case; Two Islamic terrorists arrested for conspiracy
News

Udaipur beheading case; Two Islamic terrorists arrested for conspiracy

Gold smuggling case; Swapna Suresh appeared before ED
News

Gold smuggling case; Swapna Suresh appeared before ED

Eknath Shinde sworn in as Maharashtra CM; Devendra Fadnavis Deputy CM
News

Eknath Shinde sworn in as Maharashtra CM; Devendra Fadnavis Deputy CM

Latest News

Afghanistan: Grenade attack on seminary school; 8 injured

Afghanistan: Grenade attack on seminary school; 8 injured

50th Human Rights Council Session; India to protect women’s rights in Afghanistan

50th Human Rights Council Session; India to protect women’s rights in Afghanistan

 Landslide in Manipur: 81 killed, 18 bodies recovered

 Landslide in Manipur: 81 killed, 18 bodies recovered

PC George arrested: Action taken on a harassment case filed by the accused in solar case

PC George arrested: Action taken on a harassment case filed by the accused in solar case

Smoke appears from Spicejet Cabin: Flight immediately landed in Delhi

Smoke appears from Spicejet Cabin: Flight immediately landed in Delhi

Stop spreading false news about husband’s death: Actor Meena requested

Stop spreading false news about husband’s death: Actor Meena requested

A Hindu girl raped and converted to Islam

A Hindu girl raped and converted to Islam

The majority must be proved by tomorrow evening: Governor ordered Thackeray Government

Party took action against Eknath Shinde: removed from all positions, says Uddhav Thackeray

  • Janam TV Malayalam
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Services

© Janam Multimedia Limited

No Result
View All Result
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto

© Janam Multimedia Limited